@ ALPS 2022 Conference on psychedelics


Prof. MD. Research group leader at University of Basel

PhD Student at University of Zurich

Christopher Timmerman

Postdoc. Centre for Psychedelic Research. Imperial College London

Psychiatrist and psychotherapist, specialist in addictions. University of Fribourg

Philosophy Dr. Research Fellow and Associate Lecturer at University of Exeter

PhD, postdoctoral fellow at Clinical Anatomy Lab, University of Zurich & Psychopharmacology Lab, University Hospital Bern

Professor of Psychiatry and Psychotherapy at Hannover Medical School, Germany

Associate Professor at Maastricht University

PhD Ecologist & Research collaborator at Centre for Psychedelic Research - Imperial College

MD, Chief Medical Officer at AWAKN Life Sciences

Expert in Sexual & Gender-Based Violence.

PhD Candidate at University of Zurich

Rick Doblin (Online)

Ph.D., Founder and Executive Director of the Multidisciplinary Association for Psychedelic Studies (MAPS)

Panel Speakers

PhD; Post-Doc at Psychopharmacology Research group (Prof. M. Liechti) University of Basel

Public health official at BAG

MD; Psychiatrist at Geneva University Hospital, specialized in Psychiatry and Addictology

MD; LSD researcher; Psychiatrist Psychotherapist FMH; Professor at University of Fribourg

MD, spokesperson of the Swiss Medical Association for Psycholytic Therapy (SAEPT) related to Psychedelic assisted Therapy (PAT).